<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">23850676</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>10</Month>
            <Day>21</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1090-2104</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>437</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2013</Year>
                        <Month>Aug</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biochemical and biophysical research communications</Title>
                <ISOAbbreviation>Biochem. Biophys. Res. Commun.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Propranolol, a β-adrenoceptor antagonist, worsens liver injury in a model of non-alcoholic steatohepatitis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>597-602</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbrc.2013.07.005</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0006-291X(13)01145-5</ELocationID>
            <Abstract>
                <AbstractText>Prazosin an α1-adrenoceptor (AR) antagonist has been shown to reduce liver injury in a mouse model of non-alcoholic steatohepatitis (NASH) and is suggested as a potential treatment of NASH especially given its concomitant anti-fibrotic properties. The effect however, of β-AR blockade in non-cirrhotic NASH is unknown and is as such investigated here. In the presence of the β-blocker propranolol (PRL), mice fed normal chow or a half methionine and choline deficient diet, supplemented with ethionine (HMCDE), to induce NASH, showed significantly enhanced liver injury, as evidenced by higher hepatic necrosis scores and elevated serum aminotransferases (ALT). Mechanistically, we showed that murine hepatocytes express α and β adrenoceptors; that PRL directly induces hepatocyte injury and death as evidenced by increased release of lactate dehydrogenase, FASL and TNF-α from hepatocytes in the presence of PRL; and that PRL activated the apoptotic pathway in primary hepatocyte cultures, as indicated by upregulation of Fas receptor and caspase-8 proteins. The β-AR antagonist PRL therefore appears to enhance liver injury through induction of hepatocyte death via the death pathway. Further studies are now required to extrapolate these findings to humans but meanwhile, β-AR antagonists should be avoided or used with caution in patients with non-cirrhotic NASH as they may worsen liver injury.</AbstractText>
                <CopyrightInformation>Copyright © 2013. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>McKee</LastName>
                    <ForeName>Chad</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Liver and Digestive Health, University College London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soeda</LastName>
                    <ForeName>Junpei</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Asilmaz</LastName>
                    <ForeName>Esra</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sigalla</LastName>
                    <ForeName>Barbara</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morgan</LastName>
                    <ForeName>Maelle</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sinelli</LastName>
                    <ForeName>Nicoletta</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roskams</LastName>
                    <ForeName>Tania</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oben</LastName>
                    <ForeName>Jude A</ForeName>
                    <Initials>JA</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <Agency>Wellcome Trust</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2013</Year>
                <Month>07</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biochem Biophys Res Commun</MedlineTA>
            <NlmUniqueID>0372516</NlmUniqueID>
            <ISSNLinking>0006-291X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D003470">Culture Media</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D053222">Fas Ligand Protein</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D011943">Receptors, Adrenergic, beta</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>9Y8NXQ24VQ</RegistryNumber>
                <NameOfSubstance UI="D011433">Propranolol</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.1.1.27</RegistryNumber>
                <NameOfSubstance UI="D007770">L-Lactate Dehydrogenase</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.6.1.2</RegistryNumber>
                <NameOfSubstance UI="D000410">Alanine Transaminase</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>N91BDP6H0X</RegistryNumber>
                <NameOfSubstance UI="D002794">Choline</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>WX1BN24WZT</RegistryNumber>
                <NameOfSubstance UI="D005001">Ethionine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000319" MajorTopicYN="N">Adrenergic beta-Antagonists</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000410" MajorTopicYN="N">Alanine Transaminase</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002794" MajorTopicYN="N">Choline</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003470" MajorTopicYN="N">Culture Media</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005001" MajorTopicYN="N">Ethionine</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D053222" MajorTopicYN="N">Fas Ligand Protein</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005234" MajorTopicYN="N">Fatty Liver</DescriptorName>
                <QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName>
                <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007770" MajorTopicYN="N">L-Lactate Dehydrogenase</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
                <QualifierName UI="Q000293" MajorTopicYN="Y">injuries</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D065626" MajorTopicYN="N">Non-alcoholic Fatty Liver Disease</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011433" MajorTopicYN="N">Propranolol</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011943" MajorTopicYN="N">Receptors, Adrenergic, beta</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName>
                <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Apoptosis</Keyword>
            <Keyword MajorTopicYN="N">HPC</Keyword>
            <Keyword MajorTopicYN="N">Hepatocytes</Keyword>
            <Keyword MajorTopicYN="N">NAFLD</Keyword>
            <Keyword MajorTopicYN="N">NASH</Keyword>
            <Keyword MajorTopicYN="N">Non-alcoholic fatty liver disease</Keyword>
            <Keyword MajorTopicYN="N">OC</Keyword>
            <Keyword MajorTopicYN="N">PRL</Keyword>
            <Keyword MajorTopicYN="N">PRZ</Keyword>
            <Keyword MajorTopicYN="N">Propranolol</Keyword>
            <Keyword MajorTopicYN="N">Sympathetic nervous system</Keyword>
            <Keyword MajorTopicYN="N">hepatic progenitor cell</Keyword>
            <Keyword MajorTopicYN="N">non-alcoholic fatty liver disease</Keyword>
            <Keyword MajorTopicYN="N">non-alcoholic steatohepatitis</Keyword>
            <Keyword MajorTopicYN="N">oval cell</Keyword>
            <Keyword MajorTopicYN="N">prazosin</Keyword>
            <Keyword MajorTopicYN="N">propranolol</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>06</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2013</Year>
                <Month>07</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>7</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>7</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23850676</ArticleId>
            <ArticleId IdType="pii">S0006-291X(13)01145-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbrc.2013.07.005</ArticleId>
            <ArticleId IdType="pmc">PMC5226920</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2003 Mar 21;302(4):685-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12646223</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2003 Aug 22;308(2):284-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12901866</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2004 Mar;53(3):438-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14960531</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1983 Dec 22;309(25):1539-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6361553</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Physiol. 1992 Jul;152(1):79-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1320040</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Immunol. 2003 Jun;15(3):185-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14563117</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2001 Sep;34(3):519-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11526537</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Endocrinology. 1991 Aug;129(2):1116-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1649740</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Obes Rev. 2007 Mar;8 Suppl 1:13-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17316295</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Gastrointest Liver Physiol. 2006 Jul;291(1):G55-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16439472</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2008;48 Suppl 1:S104-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18304679</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pathol. 2003 Feb;199(2):191-200</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12533832</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2004 Dec;40(6):1387-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15565570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2001 Jan;33(1):148-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11124831</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8078-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12048252</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Obes Rev. 2005 Feb;6(1):11-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15655034</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Apoptosis. 2006 Dec;11(12 ):2237-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17051329</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 2003 Sep;38(3):664-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12939593</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2002 Apr 4;416(6880):542-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11932747</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2005 Nov 24;353(21):2254-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16306522</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes Care. 2007 May;30(5):1212-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17277038</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2003 Jun 11;289(22):3000-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12799409</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anat Rec A Discov Mol Cell Evol Biol. 2004 Sep;280(1):874-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15382023</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>